BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 23, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Jan. 20, 2026

View Archived Issues
Abbott Laboratories Tactiflex Duo

Abbott's Tactiflex gains CE mark

Abbott Laboratories received CE mark in Europe for the Tactiflex Duo ablation catheter to treat patients with atrial fibrillation. The first commercial cases using Tactiflex Duo, a dual energy device, were completed in the EU this week. Read More
Artificial intelligence (AI), machine learning concept art

Wlanholding CEO says it may be too early to trust AI in health care

Investors continue to pour capital into AI-driven health care technologies, from drug discovery and diagnostics to personalized medicine and clinical decision-support tools. However, there remain issues with the quality and reliability of the data underpinning these systems, as well as the viability of their business model. Read More
Rakuten

Rakuten closes $100M series F round, teams with Lotte Biologics

Rakuten Medical Inc. raised $100 million in a series F round to support late-stage clinical development of ASP-1929, its Alluminox-derived photoimmunotherapy being tested with Keytruda (pembrolizumab) as a first-line treatment for recurrent head and neck cancer. Read More
Decorative scales of justice in a courtroom

FY 2025 a banner year for US False Claims Act recoveries

The U.S. Department of Justice said recoveries under the False Claims Act in fiscal year 2025 reached a record of more than $6.8 billion, more than 80% of which came from health care cases. Read More
CMS-medicare-reimbursement.png

Medicare improper payment rate down in FY 2025

The U.S. Centers for Medicare & Medicaid Services announced Jan. 15 that the estimated volume of improper payments for Medicare fee-for-service care in fiscal 2025 was nearly $29 billion while the number for Medicare managed care was in excess of $23 billion. Read More

Med-tech gainers and losers for Jan. 12-16, 2026

The top 10 med-tech stock gainers and losers for the week. Read More

Holiday notice

BioWorld's offices were closed in observance of Martin Luther King Jr. Day in the U.S. No issue was published Monday, Jan. 19. Read More

Appointments and advancements for Jan. 20, 2026

New hires and promotions in the med-tech industry, including: Major Medical Devices, Vygon. Read More

Financings for Jan. 20, 2026

Med-tech firms raising money in public or private financings, including: Tricares. Read More

In the clinic for Jan. 20, 2026

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Orlucent. Read More

Other news to note for Jan. 20, 2026

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aorticlab, Avanos Medical, Brainomix, Capitan Orthopedics, Emboline, Genesis Innovation, Illumina, Serres, Siemens Healthineers. Read More

Regulatory actions for Jan. 20, 2026

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott Labs, Cepheid. Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 17, 2026
  • SERCA inhibitor from Sumitomo shows promise for MSA-C treatment

    BioWorld Science
    At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing